GB201615916D0 - Pharmaceutical compound - Google Patents
Pharmaceutical compoundInfo
- Publication number
- GB201615916D0 GB201615916D0 GBGB1615916.2A GB201615916A GB201615916D0 GB 201615916 D0 GB201615916 D0 GB 201615916D0 GB 201615916 A GB201615916 A GB 201615916A GB 201615916 D0 GB201615916 D0 GB 201615916D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compound
- pharmaceutical
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/74—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C215/76—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton of the same non-condensed six-membered aromatic ring
Priority Applications (24)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1615916.2A GB2554092A (en) | 2016-09-19 | 2016-09-19 | Pharmaceutical composition |
MX2018006800A MX2018006800A (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition. |
CA3007050A CA3007050C (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition comprising a formoterol compound |
AU2016364650A AU2016364650B2 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
EP20169450.2A EP3701940A1 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
CN201680071126.5A CN108289843B (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
US15/781,045 US11559505B2 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
BR122020022602-1A BR122020022602B1 (en) | 2015-12-04 | 2016-12-02 | PHARMACEUTICAL COMPOSITION |
EP16822716.3A EP3383366B1 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
ES19178843T ES2866175T3 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
ES19178832T ES2869176T3 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
EP19178832.2A EP3556347B1 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
CN202011316904.7A CN112472689B (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
PCT/GB2016/053812 WO2017093758A1 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
EP19178843.9A EP3556348B1 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
JP2018528946A JP6899824B2 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
BR112018011266-6A BR112018011266B1 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition, sealed container, and, methods for treating a patient suffering from or prone to suffering from a respiratory disorder and for stabilizing a pharmaceutical composition |
ES16822716T ES2796177T3 (en) | 2015-12-04 | 2016-12-02 | Pharmaceutical composition |
AU2019202875A AU2019202875B2 (en) | 2015-12-04 | 2019-04-24 | Pharmaceutical composition |
AU2019202874A AU2019202874C1 (en) | 2015-12-04 | 2019-04-24 | Pharmaceutical composition |
US16/575,168 US11559507B2 (en) | 2015-12-04 | 2019-09-18 | Pharmaceutical composition |
US16/575,069 US11559506B2 (en) | 2015-12-04 | 2019-09-18 | Pharmaceutical composition |
JP2019232073A JP6931383B2 (en) | 2015-12-04 | 2019-12-23 | Pharmaceutical composition |
JP2019232074A JP6899889B2 (en) | 2015-12-04 | 2019-12-23 | Pharmaceutical composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1615916.2A GB2554092A (en) | 2016-09-19 | 2016-09-19 | Pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201615916D0 true GB201615916D0 (en) | 2016-11-02 |
GB2554092A GB2554092A (en) | 2018-03-28 |
Family
ID=57288867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1615916.2A Withdrawn GB2554092A (en) | 2015-12-04 | 2016-09-19 | Pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2554092A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2584686A (en) * | 2019-06-11 | 2020-12-16 | Mexichem Fluor Sa De Cv | Methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201108039D0 (en) * | 2011-05-13 | 2011-06-29 | Mexichem Amanco Holding Sa | Compositions |
CN102362860A (en) * | 2011-10-27 | 2012-02-29 | 江阴长风医药科技有限公司 | Budesonide and formoterol aerosol preparation taking hydro-fluoro-alkane as propellant |
-
2016
- 2016-09-19 GB GB1615916.2A patent/GB2554092A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2554092A (en) | 2018-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL266017A (en) | Pharmaceutical compounds | |
GB201612092D0 (en) | Pharmaceutical compounds | |
IL258213A (en) | Pharmaceutical compounds | |
GB201511790D0 (en) | Pharmaceutical compound | |
GB201617758D0 (en) | Pharmaceutical compounds | |
GB201506658D0 (en) | Pharmaceutical compounds | |
GB201504675D0 (en) | Pharmaceutical compounds | |
GB201506660D0 (en) | Pharmaceutical compounds | |
ZA201900540B (en) | Pharmaceutical compounds | |
GB201519352D0 (en) | Pharmaceutical compounds | |
GB201517216D0 (en) | Pharmaceutical compounds | |
HUE052107T2 (en) | Pharmaceutical compounds | |
GB201612095D0 (en) | Pharmaceutical compounds | |
GB201617454D0 (en) | Pharmaceutical compounds | |
GB201516411D0 (en) | Pharmaceutical compound | |
GB201506933D0 (en) | Pharmaceutical compounds | |
GB201502567D0 (en) | Pharmaceutical compounds | |
GB201617871D0 (en) | Pharmaceutical compounds | |
SG11201708818VA (en) | Pharmaceutical compound | |
ZA201904033B (en) | Pharmaceutical compounds | |
GB201615916D0 (en) | Pharmaceutical compound | |
GB201615912D0 (en) | Pharmaceutical compound | |
HK1226067B (en) | Pharmaceutical compounds | |
GB201614037D0 (en) | Pharmaceutical compounds | |
SG11201708817XA (en) | Pharmaceutical compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |